BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17704805)

  • 1. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells.
    Suprynowicz FA; Disbrow GL; Krawczyk E; Simic V; Lantzky K; Schlegel R
    Oncogene; 2008 Feb; 27(8):1071-8. PubMed ID: 17704805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells.
    Boulenouar S; Weyn C; Van Noppen M; Moussa Ali M; Favre M; Delvenne PO; Bex F; Noël A; Englert Y; Fontaine V
    Carcinogenesis; 2010 Mar; 31(3):473-80. PubMed ID: 19917629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein.
    Kim SH; Oh JM; No JH; Bang YJ; Juhnn YS; Song YS
    Carcinogenesis; 2009 May; 30(5):753-7. PubMed ID: 19321801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.
    Kim MK; Kim HS; Kim SH; Oh JM; Han JY; Lim JM; Juhnn YS; Song YS
    Biochem Pharmacol; 2010 Dec; 80(12):1930-5. PubMed ID: 20643111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of GM1 enhances cell proliferation with epidermal growth factor without affecting the receptor localization in the microdomain in PC12 cells.
    Nishio M; Tajima O; Furukawa K; Urano T; Furukawa K
    Int J Oncol; 2005 Jan; 26(1):191-9. PubMed ID: 15586240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
    Yugawa T; Kiyono T
    Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 and lipid rafts in confluent BeWo trophoblasts: evidence for Rock-1 association with caveolin-1.
    Rashid-Doubell F; Tannetta D; Redman CW; Sargent IL; Boyd CA; Linton EA
    Placenta; 2007; 28(2-3):139-51. PubMed ID: 16480767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
    Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
    Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.
    Oh JM; Kim SH; Lee YI; Seo M; Kim SY; Song YS; Kim WH; Juhnn YS
    Carcinogenesis; 2009 Jan; 30(1):141-9. PubMed ID: 18849297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.
    Bottley G; Watherston OG; Hiew YL; Norrild B; Cook GP; Blair GE
    Oncogene; 2008 Mar; 27(12):1794-9. PubMed ID: 17828295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of estrogen receptor beta with plasma-membrane caveola components: implication in control of vitamin D receptor.
    Gilad LA; Schwartz B
    J Mol Endocrinol; 2007 Jun; 38(6):603-18. PubMed ID: 17556531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolae facilitate but are not essential for platelet-activating factor-mediated calcium mobilization and extracellular signal-regulated kinase activation.
    Poisson C; Rollin S; Véronneau S; Bousquet SM; Larrivée JF; Le Gouill C; Boulay G; Stankova J; Rola-Pleszczynski M
    J Immunol; 2009 Aug; 183(4):2747-57. PubMed ID: 19620302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
    Kiyan J; Smith G; Haller H; Dumler I
    Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biochemical and biological functions of human papillomavirus type 16 E5 protein.
    Tsai TC; Chen SL
    Arch Virol; 2003 Aug; 148(8):1445-53. PubMed ID: 12898324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside GM1 levels are a determinant of the extent of caveolae/raft-dependent endocytosis of cholera toxin to the Golgi apparatus.
    Pang H; Le PU; Nabi IR
    J Cell Sci; 2004 Mar; 117(Pt 8):1421-30. PubMed ID: 14996913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGF induces coalescence of different lipid rafts.
    Hofman EG; Ruonala MO; Bader AN; van den Heuvel D; Voortman J; Roovers RC; Verkleij AJ; Gerritsen HC; van Bergen En Henegouwen PM
    J Cell Sci; 2008 Aug; 121(Pt 15):2519-28. PubMed ID: 18628305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of caveolin-1 in a human melanoma cell line results in dispersion of ganglioside GD3 from lipid rafts and alteration of leading edges, leading to attenuation of malignant properties.
    Nakashima H; Hamamura K; Houjou T; Taguchi R; Yamamoto N; Mitsudo K; Tohnai I; Ueda M; Urano T; Furukawa K; Furukawa K
    Cancer Sci; 2007 Apr; 98(4):512-20. PubMed ID: 17284246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
    Yamaguchi H; Takeo Y; Yoshida S; Kouchi Z; Nakamura Y; Fukami K
    Cancer Res; 2009 Nov; 69(22):8594-602. PubMed ID: 19887621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation.
    Fehrmann F; Laimins LA
    Oncogene; 2003 Aug; 22(33):5201-7. PubMed ID: 12910257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.